Tag Archives: Permissible indications

Complementary medicine weight loss products complaints submitted to the TGA in 2018-2019. Follow-up.

This research was conducted by a team of Monash University BSc students on a Work Integrated Learning (WIL) placement, supervised by Assoc Prof Ken Harvey. The team reviewed the following complaints submitted on: 6 July 2018, Pharmacare Laboratories FatBlaster FatMagnet products, … Continue reading

Posted in Advertising, Complementary medicine, Weight loss | Tagged , , , , , | Leave a comment

TGA Advertising Portal and Complaint System now live; Industry embrace permissible indications

See: https://www.tga.gov.au/advertising-hub and: https://ajp.com.au/news/tga-explains-new-advertising-landscape/ However, there are still concerns about the transparency of the new system and my colleagues and I are holding off submitting complaints until we know: The outcome of the TGA Consultation: Complaints handling – Advertising therapeutic goods to … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , | Leave a comment